TGA Approval

JAKAVI ruxolitinib (as phosphate) 10 mg tablet blister pack (232702)

ARTG ID

232702

ARTG Name

JAKAVI ruxolitinib (as phosphate) 10 mg tablet blister pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

December 16, 2015

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-CMI-01925-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-PI-01918-1

Ingredient Name

ruxolitinib phosphate

Empowering clinical research with data-driven insights and AI-powered tools.

JAKAVI ruxolitinib (as phosphate) 10 mg tablet blister pack (232702) - TGA 批准文号 | MedPath